Results 231 to 240 of about 658,841 (317)

GEMap: A comprehensive gene essentiality map for drug discovery. [PDF]

Acta Pharm Sin B
Tian S, Liang Y, Zhang J, Liang W, Lu J, Ren J, Lin B, Wu R, Guo C, Zhang W.   +9 more
europepmc   +1 more source

Mammalian Cell Line Development Platform for Recombinant Protein Production: Expanding the Protein Expression Toolbox for Research and Drug Discovery Applications

, 2017
Elizabeth Del Greco
openalex   +2 more sources

RNA Sequencing Resolves Cryptic Pathogenic Variants in Mitochondrial Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Mitochondrial diseases are the most common inherited metabolic disorders, characterized by pronounced clinical and genetic heterogeneity that complicates molecular diagnosis. Although DNA‐based sequencing approaches have become standard in genetic testing, up to half of patients remain without a definitive diagnosis.
Zhimei Liu, Xin Duan, Fatemeh Peymani, Jia Wang, Chengjia Bao, Chaolong Xu, Ying Zou, Zixuan Zhang, Yunxi Zhang, Tongyue Li, Martin Pavlov, Junling Wang, Minhan Song, Tianyu Song, Xiaodi Han, Mingxi Sun, Danmin Shen, Ruoyu Duan, Huafang Jiang, Manting Xu, Holger Prokisch, Fang Fang   +21 more
wiley   +1 more source

Developmental Programming of Drug Response: Microbiota as a Missing Dimension in Perinatal Drug Discovery. [PDF]

Int J Mol Sci
Zhang Y, Ma L, Wang Y.
europepmc   +1 more source

Bioinformatics-Driven Drug Discovery for Breast Cancer: A Focus on Natural Compounds [PDF]

Ruquaiya Quddus
openalex   +1 more source

Advancing Age Modulates Associations Between Cognitive Impairment and Brain Volumes in Early MS

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Introduction Cognitive impairment is common in multiple sclerosis (MS), but manifestations following the first demyelinating event are relatively unexplored. We investigated cross‐sectional associations between magnetic resonance imaging (MRI)–derived brain volumes and the presence of cognitive impairment outcomes five years after the first ...
Piriyankan Ananthavarathan, Marco Pitteri, Michael Foster, Sara Collorone, Sara Salama, Elisa Colato, Ferran Prados, Baris Kanber, Marios Yiannakas, Claudia A. M. Gandini Wheeler‐Kingshott, Indran Davagnanam, Frederik Barkhof, Declan Chard, Olga Ciccarelli, Ahmed Toosy   +14 more
wiley   +1 more source

More protein-ligand data are needed for AlphaFold-like models to enable drug discovery. [PDF]

Curr Opin Struct Biol
Singh S, Clerkin AB, Castellanos MA, Chodera JD.   +3 more
europepmc   +1 more source

Medicinal Plants against Malaria and Dengue: In-Silico Computational Drug Discovery Framework for Identifying Therapeutic Leads

openalex   +1 more source

Comparing the Effect of Semi‐Immersive Virtual Reality, Computerized Cognitive Training, and Traditional Rehabilitation on Cognitive Function in Multiple Sclerosis: A Randomized Clinical Trial

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Cognitive impairment is a common non‐motor symptom in Multiple Sclerosis (MS), negatively affecting autonomy and Quality of Life (QoL). Innovative rehabilitation strategies, such as semi‐immersive virtual reality (VR) and computerized cognitive training (CCT), may offer advantages over traditional cognitive rehabilitation (TCR ...
Maria Grazia Maggio, Desiree Latella, Lilla Bonanno, Paulo Cezar Rocha dos Santos, Marcos Maldonado‐Díaz, Meir Plotnik, Rosaria De Luca, Angelo Quartarone, Rocco Salvatore Calabrò   +8 more
wiley   +1 more source

NMR-Based Fragment Screening for RNA-Targeted Drug Discovery. [PDF]

Molecules
Petersen RJ, Wang Y.
europepmc   +1 more source